Diane Liu, M.S.

Senior Statistical Analyst

Department of Biostatistics

The University of Texas M. D. Anderson Cancer Center

 

 

            Some recent publications in peer-reviewed journals:

 

  • Jeha S, Smith FO, Estey E, Shen Y, Liu D, Manshouri T, Albitar M. Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels. Leukemia Research 2002; 26(4):399-402.

 

  • Shin DM, Glisson BS, Khuri FR, Clifford JL, Clayman G, Benner SE, Forastiere AA, Ginsberg L, Liu D, Lee JJ, Myers J, Goepfert H, Lotan R, Hong WK, Lippman SM.  Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancer. Journal of Clinical Oncology 2002; 20(2):364-370.

 

  • Soria JC, Moon C, Wang L, Hittelman WN, Jang SJ, Sun SY, Lee JJ, Liu D, Kurie JM, Morice RC, Lee JS, Hong WK, Mao L. Effects of N-(4-hydroxyphenyl)retinamide on hTERT expression in the bronchial epithelium of cigarette smokers. Journal of the National Cancer Institute 2001; 93(16):1257-1263.

 

  • Lee JJ, Liu D, Lee JS, Kurie JM, Khuri FR, Ibarguen H, Morice RC, Walsh G, Ro JY, Broxson A, Hong WK, Hittelman WN. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. Journal of the National Cancer Institute 2001; 93(14):1081-1088.

 

  • Papadimitrakopoulou VA, Izzo J, Mao L, Keck J, Hamilton D, Shin DM, El-Naggar A, den Hollander P, Liu D, Hittelman WN, Hong WK. Cyclin D1 and p16 alterations in advanced premalignant lesions of the upper aerodigestive tract: role in response to chemoprevention and cancer development. Clinical Cancer Research 2001; 7(10):3127-3134.

 

  • Kim ES, Lu C, Khuri FR, Tonda M, Glisson BS, Liu D, Jung M, Hong WK, Herbst RS.  A phase II study of STEALTH cisplatin (SPI-77) in patients with advanced non-small cell lung cancer. Lung Cancer 2001; 34(3):427-432.

 

  • Hassan KA, El-Naggar AK, Soria JC, Liu D, Hong WK, Mao L. Clinical significance of cyclin B1 protein expression in squamous cell carcinoma of the tongue. Clinical Cancer Research 2001; 7(8):2458-2462.

 

·        Kurie JM, Lee JS, Khuri FR, Mao L, Morice RC, Lee JJ, Walsh GL, Broxson A, Lippman SM, Ro JY, Kemp BL, Liu D, Fritsche HA, Xu XC, Lotan R, Hong WK.   N-(4-hydroxyphenyl) retinamide in the chemoprevention of squamous metaplasia and dysplasia of the bronchial epithelium.   Clinical Cancer Research 2000; 6(8): 2973-2979.

 

·        Tang X, Khuri FR, Lee JJ, Kemp BL, Liu D, Hong WK, Mao L. Hypermethylation of the death-associated protein (DAP) kinase promoter and aggressiveness in stage I non-small-cell lung cancer.

·        Journal of the National Cancer Institute 2000; 92(18):1511-1516.

 

·        Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L.  Overexpression of cyclin B1 in early stage non-small cell lung cancer and its clinical implication. Cancer Research 2000; 60(15):4000-4004.

 

·        Herbst RS, Yano S, Kuniyasu H, Khuri FR, Bucana CD, Guo F, Liu D, Kemp BL, Lee JJ, Hong WK, Fidler IJ.  Diiferential expression of E-cadherin and type IV collagenase genes predicts outcome in patients with stage I non-small cell lung carcinoma.  Clinical Cancer Research 2000; 6(3):790-797.

 

·        Zhou X, Kemp BL, Khuri FR, Liu D, Lee JJ, Wu W, Hong WK, Mao L.  Prognostic implication of microsatellite alteration profiles in early-stage non-small cell lung cancer. Clinical Cancer Research 2000; 6(2):559-565.

 

·        Tseng JE, Rodriguez M, Ro J, Liu D, Hong WK, Mao L.  Gender difference in p53 mutational status in small cell lung cancer. Cancer Research 1999; 59(22):5666-5670.

 

·        Tseng JE, Kemp BL, Khuri FR, Kurie JM, Lee JS, Zhou X, Liu D, Hong WK, Mao L.  Loss of Fhit is frequent in stage I non-small cell lung cancer and in the lungs of chronic smokers. Cancer Research 1999; 59(19):4798–4803.